Renal graft function outcomes after conversion from conventional immunosuppression regimen to belatacept plus low dose calcineurin inhibitor regimen: a single center study

Transplantation Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles